Pharmacokinetic Interactions of Clinical Interest Between Direct Oral Anticoagulants and Antiepileptic Drugs
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacokinetic Interactions of Clinical Interest Between Direct Oral Anticoagulants and Antiepileptic Drugs
Authors
Keywords
-
Journal
Frontiers in Neurology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-12-07
DOI
10.3389/fneur.2018.01067
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Management of Phenobarbital and Apixaban Interaction in Recurrent Cardioembolic Stroke
- (2018) Philip K. King et al. ANNALS OF PHARMACOTHERAPY
- Lesson of the month 2: Pulmonary embolism in a patient on rivaroxaban and concurrent carbamazepine
- (2018) Thomas Burden et al. CLINICAL MEDICINE
- Efficacy and safety of outpatient treatment with direct oral anticoagulation in pulmonary embolism
- (2018) R. Ghazvinian et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Epilepsy
- (2018) Orrin Devinsky et al. Nature Reviews Disease Primers
- Pharmacokinetics of new oral anticoagulants: implications for use in routine care
- (2018) Ylenia Ingrasciotta et al. Expert Opinion on Drug Metabolism & Toxicology
- Association Between Use of Non–Vitamin K Oral Anticoagulants With and Without Concurrent Medications and Risk of Major Bleeding in Nonvalvular Atrial Fibrillation
- (2017) Shang-Hung Chang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Recurrent venous thrombosis under rivaroxaban and carbamazepine for symptomatic epilepsy
- (2017) Claudia Stöllberger et al. Neurologia i Neurochirurgia Polska
- Incidence and management of seizures after ischemic stroke
- (2017) Jeffrey Z. Wang et al. NEUROLOGY
- Measurement of Dabigatran Drug Levels to Manage Patients Taking Interacting Drugs: A Case Report
- (2016) Marissa Laureano et al. AMERICAN JOURNAL OF MEDICINE
- Impact of perampanel on pharmacokinetics of concomitant antiepileptics in patients with partial-onset seizures: pooled analysis of clinical trials
- (2016) Oneeb Majid et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
- (2016) Paulus Kirchhof et al. EUROPEAN HEART JOURNAL
- Clinically significant pharmacokinetic drug interactions of antiepileptic drugs with new antidepressants and new antipsychotics
- (2016) Edoardo Spina et al. PHARMACOLOGICAL RESEARCH
- Reduced Anticoagulant Effect of Dabigatran in a Patient Receiving Concomitant Phenytoin
- (2016) Barbara S. Wiggins et al. PHARMACOTHERAPY
- A pharmacological overview of lamotrigine for the treatment of epilepsy
- (2016) Venkata Ramesh Yasam et al. Expert Review of Clinical Pharmacology
- Impact of Genetic Polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on Drug Disposition and Potential Clinical Implications: Update of the Literature
- (2015) Stefan Wolking et al. CLINICAL PHARMACOKINETICS
- Clinical Pharmacokinetic and Pharmacodynamic Profile of Lacosamide
- (2015) Willi Cawello CLINICAL PHARMACOKINETICS
- Evaluation of cytochrome P450 inductions by anti-epileptic drug oxcarbazepine, 10-hydroxyoxcarbazepine, and carbamazepine using human hepatocytes and HepaRG cells
- (2015) Ikuo Sugiyama et al. XENOBIOTICA
- The clinical pharmacology profile of the new antiepileptic drug perampanel: A novel noncompetitive AMPA receptor antagonist
- (2014) Philip N. Patsalos EPILEPSIA
- Pharmacokinetic and pharmacodynamic interactions between antiepileptics and antidepressants
- (2014) Domenico Italiano et al. Expert Opinion on Drug Metabolism & Toxicology
- Prolonged anticoagulant activity of rivaroxaban in a polymorbid elderly female with non-convulsive epileptic state
- (2014) Claudia Stöllberger et al. HEART & LUNG
- Correlation Between Trough Plasma Dabigatran Concentrations and Estimates of Glomerular Filtration Rate Based on Creatinine and Cystatin C
- (2014) Paul K. L. Chin et al. Drugs in research & development
- Drug Interactions with the Newer Antiepileptic Drugs (AEDs)—Part 2: Pharmacokinetic and Pharmacodynamic Interactions Between AEDs and Drugs Used to Treat Non-Epilepsy Disorders
- (2013) Philip N. Patsalos CLINICAL PHARMACOKINETICS
- Drug Interactions with the Newer Antiepileptic Drugs (AEDs)—Part 1: Pharmacokinetic and Pharmacodynamic Interactions Between AEDs
- (2013) Philip N. Patsalos CLINICAL PHARMACOKINETICS
- Concerns About the Use of New Oral Anticoagulants for Stroke Prevention in Elderly Patients with Atrial Fibrillation
- (2013) Claudia Stöllberger et al. DRUGS & AGING
- Impact of P-glycoprotein and breast cancer resistance protein on the brain distribution of antiepileptic drugs in knockout mouse models
- (2013) Haruka Nakanishi et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Clinical Pharmacology and Pharmacokinetics of Levetiracetam
- (2013) Chanin Wright et al. Frontiers in Neurology
- Oral bioavailability of dabigatran etexilate (Pradaxa®) after co-medication with verapamil in healthy subjects
- (2012) Sebastian Härtter et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Psychotropic Drug–Drug Interactions Involving P-Glycoprotein
- (2012) Yumiko Akamine et al. CNS DRUGS
- Pharmacokinetic and pharmacodynamic profile of pregabalin and its role in the treatment of epilepsy
- (2012) Andreas Schulze-Bonhage Expert Opinion on Drug Metabolism & Toxicology
- The transport of antiepileptic drugs by P-glycoprotein
- (2011) Chunbo Zhang et al. ADVANCED DRUG DELIVERY REVIEWS
- Interactions between antidepressants and P-glycoprotein at the blood-brain barrier: clinical significance of in vitro and in vivo findings
- (2011) Fionn E O'Brien et al. BRITISH JOURNAL OF PHARMACOLOGY
- Influence of Efflux Transporters on Drug Metabolism
- (2011) Pietro Fagiolino et al. CLINICAL PHARMACOKINETICS
- In vitro transport profile of carbamazepine, oxcarbazepine, eslicarbazepine acetate, and their active metabolites by human P-glycoprotein
- (2011) Chunbo Zhang et al. EPILEPSIA
- Antiepileptic drugs modulate P-glycoproteins in the brain: A mice study with 11C-desmethylloperamide
- (2011) Lieselotte Moerman et al. EPILEPSY RESEARCH
- In Vitro and In Vivo P-Glycoprotein Transport Characteristics of Rivaroxaban
- (2011) M. J. Gnoth et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Rivaroxaban: A New Oral Factor Xa Inhibitor
- (2010) Elisabeth Perzborn et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Combined effects of epileptic seizure and phenobarbital induced overexpression of P-glycoprotein in brain of chemically kindled rats
- (2010) Xinyue Jing et al. BRITISH JOURNAL OF PHARMACOLOGY
- Pharmacology, Pharmacokinetics, and Pharmacodynamics of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor
- (2009) Joachim Stangier et al. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
- Metabolism and Excretion of Rivaroxaban, an Oral, Direct Factor Xa Inhibitor, in Rats, Dogs, and Humans
- (2009) C. Weinz et al. DRUG METABOLISM AND DISPOSITION
- Drug interactions involving the new second- and third-generation antiepileptic drugs
- (2009) Cecilie Johannessen Landmark et al. Expert Review of Neurotherapeutics
- SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions
- (2009) Saskia Preissner et al. NUCLEIC ACIDS RESEARCH
- Rufinamide: Clinical pharmacokinetics and concentrationresponse relationships in patients with epilepsy
- (2008) Emilio Perucca et al. EPILEPSIA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started